New hope for osteoarthritis patients suffering severe pain in hands

November 13, 2017, St. George's University of London
Credit: St. George's University of London

Osteoarthritis is the most prevalent arthritis worldwide and is characterised by chronic pain and impaired physical function.

Millions of people across the UK suffer from debilitating due to the condition and the usual care is ibuprofen and .

Patients are usually also sent for hand physiotherapy, but some say they can't continue the therapy because of the pain. However, taking part in hand physiotherapy is proven to be beneficial in the long term in preventing hands from losing movement.

The study by staff at St George's University of London, showed that a drug called pregabalin was the most effective trial treatment. Patients took two pills daily and were treated during a three month period.

Dr Nidhi Sofat, a Reader in Rheumatology, said: "Osteoarthritis is the most common form of arthritis in the world and more than 8m people have it in the UK.

"Usually, drug trials for arthritis are aimed at helping patients with problems in their knees or hips, but we wanted to focus on hands as no one had really investigated that area before.

"To tackle the pain would mean an improvement in the general wellbeing and care of patients with this condition. This led us to run a trial to try to switch off the in the brain to enable patients to manage their condition more easily.

"They reported an improvement in not only pain, but also their abilities to do daily tasks like cooking, washing dressing. They also used six times less extra pain relief than the placebo group."

The trial involved giving 65 patients different medication and monitoring their progress. During the drugs trial patients were split into groups and one group took pregabalin, the second group took duloxetine and the third group took placebo pills.

All the drugs looked the same so the did not know what they were taking.

Certain people are more prone to osteoarthritis in the hands, for example, women aged over 50.

Explore further: Clinical trial explores new ways to help chronic pain sufferers

More information: Nidhi Sofat et al. The effect of pregabalin or duloxetine on arthritis pain: a clinical and mechanistic study in people with hand osteoarthritis, Journal of Pain Research (2017). DOI: 10.2147/JPR.S147640

Related Stories

Clinical trial explores new ways to help chronic pain sufferers

December 18, 2015
Medication normally used to treat depression and anxiety could give new hope to chronic pain suffers.

Researchers find new genes link to arthritis in bone marrow lesions

July 18, 2017
Researchers have found a pattern of genes which is characteristic of osteoarthritis and may be a step towards better treatments for this condition.

Bisphosphonates could offer effective pain relief in osteoarthritis, research finds

September 6, 2013
St George's, University of London research has found that a drug normally given to osteoporosis sufferers could provide effective pain relief to patients with knee and hip osteoarthritis.

Evidence does not support the use of gabapentinoids for chronic low back pain

August 15, 2017
Existing evidence on the use of gabapentinoids in chronic low back pain (CLBP) is limited, and demonstrates significant risk of adverse effects with no benefits on pain relief, according to a meta-analysis published in PLOS ...

Quadriceps exercise relieves pain in knee osteoarthritis

June 1, 2017
(HealthDay)—A quadriceps isometric contraction exercise method is effective for relieving pain in knee osteoarthritis (OA), according to a study published online May 25 in the International Journal of Rheumatic Diseases.

No relief in sight for those suffering from sciatica

March 22, 2017
A drug increasingly being prescribed for treating sciatica has been revealed to be no better than placebo, in new research from The George Institute for Global Health.

Recommended for you

Patchy distribution of joint inflammation resolved

November 16, 2018
Chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and spondylo-arthritis (SpA) are chronic, disabling diseases with a poor outcome for loco-motoric function if left untreated. RA and SpA each affect ...

Defense against joint degeneration

October 30, 2018
During cartilage development, chondrocytes secrete the extracellular matrix (ECM) and embed within the same environment. During progressive joint disease, such as osteoarthritis (OA), dysregulation of the process can lead ...

Becoming more sensitive to pain increases the risk of knee pain not going away

October 30, 2018
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis, according to a new study by researchers at Université de Montréal and its affiliated ...

Ground-breaking discovery finds new link between autoimmune diseases and a gut bacterium

October 29, 2018
Could microbes in our guts be sending out the wrong message? Queen's University Belfast researchers have, for the first time, found a specific microbe in the gut that pumps out protein molecules that mimic a human protein, ...

Research shows diet has little influence on precursor to gout

October 11, 2018
Dietary factors have a far smaller influence on urate levels (a precursor to gout) than previously envisaged, new University of Otago research reveals.

More doctor visits lead to less suicide attempts for fibromyalgia patients

September 19, 2018
Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.